Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2
Authors
Keywords
-
Journal
VIRUS RESEARCH
Volume 319, Issue -, Pages 198857
Publisher
Elsevier BV
Online
2022-07-10
DOI
10.1016/j.virusres.2022.198857
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intranasal COVID-19 vaccines: From bench to bed
- (2022) Aqu Alu et al. EBioMedicine
- Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
- (2021) Bryan A. Johnson et al. NATURE
- SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
- (2021) Nikolaos C. Kyriakidis et al. npj Vaccines
- Should the world collaborate imminently to develop neglected live‐attenuated vaccines for COVID‐19?
- (2021) Ji‐Ming Chen JOURNAL OF MEDICAL VIROLOGY
- Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
- (2021) Shipo Wu et al. LANCET INFECTIOUS DISEASES
- Could live attenuated vaccines better control COVID-19?
- (2021) Shinya Okamura et al. VACCINE
- SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity
- (2021) Michihito Sasaki et al. mBio
- The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2
- (2021) Yujia Alina Chan et al. MOLECULAR BIOLOGY AND EVOLUTION
- Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA
- (2021) Ji Eun Oh et al. Science Immunology
- Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection
- (2021) Mariapia Guerrieri et al. Vaccines
- The protein expression profile of ACE2 in human tissues
- (2020) Feria Hikmet et al. Molecular Systems Biology
- Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway
- (2020) Qinhai Ma et al. PHYTOMEDICINE
- Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
- (2020) Andrew D. Davidson et al. Genome Medicine
- Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein
- (2020) Nouredine Behloul et al. VIRUS RESEARCH
- Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide
- (2020) Sandra Isabel et al. Scientific Reports
- Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection
- (2020) Sang Heui Seo et al. Vaccines
- Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal Responses
- (2016) John D. Clements et al. Clinical and Vaccine Immunology
- Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults
- (2016) Daniel F. Hoft et al. Clinical and Vaccine Immunology
- Efficacy and effectiveness of live attenuated influenza vaccine in school-age children
- (2015) Kathleen Coelingh et al. Expert Review of Vaccines
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started